Table 2 Characteristics of 26 IH patients with intolerable side effects during propranolol treatment.

From: Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management

Cases	Sex	Location	Age at initiation of propranolol (d)	Morphologic subtype	Description	Duration of propranolol treatment (d)	Reason for discontinuation	Two treatment Interval (d)	Following treatment	Response
1	Female	Head	46	Localized	Mixed	30	Sleep Disturbance	7	Atenolol	Excellent
2	Female	Face	42	Segmental	Deep	120	Sleep Disturbance	0	Atenolol	Excellent
3	Female	Face	102	Localized	Mixed	12	Sleep Disturbance	2	Atenolol	Excellent
4	Male	Trunk	80	Localized	Mixed	60	Hypoglycemia	14	Prednisolone	Good
5	Female	Head	61	Localized	Superficial	21	Agitation	0	Atenolol	Excellent
6	Female	Perineal	66	Localized	Mixed	150	Sleep Disturbance	90	Atenolol	Good
7	Male	Face	40	Indeterminate	Mixed	4	Bronchial hyperreactivity	31	Prednisolone	Excellent
8	Male	Neck	72	Localized	Mixed	60	Sleep Disturbance	0	Atenolol	Excellent
9	Female	Extremity	60	Multifocal	Mixed	42	Bronchospasm	28	Atenolol	Good
10	Female	Trunk	49	Localized	Mixed	77	Sleep Disturbance	35	Atenolol	Excellent
11	Female	Face	35	Indeterminate	Superficial	55	Sleep Disturbance	1	Atenolol	Excellent
12	Male	Extremity	66	Indeterminate	Mixed	240	Sleep Disturbance	0	Atenolol	Stable
13	Female	Face	52	Localized	Deep	18	Agitation	7	Atenolol	Excellent
14	Female	Head	29	Localized	Mixed	6	Sleep Disturbance	21	Atenolol	Good
15	Female	Trunk	55	Segmental	Mixed	98	Sleep Disturbance	0	Atenolol	Excellent
16	Female	Face	66	Localized	Mixed	5	Hypoglycemia	7	Atenolol	Good
17	Male	Trunk	91	Localized	Mixed	120	Sleep Disturbance	7	Atenolol	Excellent
18	Female	Neck	80	Localized	Mixed	60	Sleep Disturbance	3	Atenolol	Excellent
19	Female	Extremity	49	Localized	Mixed	6	Bronchial hyperreactivity	14	Prednisolone	Excellent
20	Male	Head	55	Localized	Superficial	25	Sleep Disturbance	0	Atenolol	Good
21	Female	Trunk	92	Localized	Mixed	18	Sleep Disturbance	3	Atenolol	Excellent
22	Female	Face	80	Indeterminate	Mixed	42	Agitation	7	Atenolol	Excellent
23	Female	Trunk	48	Localized	Mixed	140	Sleep Disturbance	2	Atenolol	Good
24	Female	Extremity	60	Localized	Mixed	22	Bronchospasm	21	Atenolol	Stable
25	Male	Trunk	76	Segmental	Mixed	81	Sleep Disturbance	0	Atenolol	Excellent
26	Female	Face	52	Localized	Superficial	75	Sleep Disturbance	1	Atenolol	Excellent

^*d, days.

Back to article page

Table 2 Characteristics of 26 IH patients with intolerable side effects during propranolol treatment.

Search

Quick links